![](/wp-content/uploads/2022/01/Other-Research-Resources-440x300-1.png")
Posts
;
Learn about the EA8191/INDICATE study, treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More information: http://bit.ly/indicate-trial #pcsm
If you are an ECOG-ACRIN member, the Spring 2025 Group Meeting session recordings are available on the Attendee Hub Website!
Log in with your first name, last name, and the email address you used during registration to view sessions you may have missed. https://cvent.me/Y5NW4q
If you are not registered, ECOG-ACRIN members can still sign up for access to the session recordings through this link: https://bit.ly/ea-spring25
How well does osimertinib—with or without chemotherapy—work to control EGFR-positive #LungCancer in patients not participating in a clinical trial? The PrE1702 #RealWorldData research study aims to find out. Learn more: https://bit.ly/pre1702-study #LCSM #RWD #RWE
About Us
The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1400 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More
Scientific Pursuits
We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More
ECOG-ACRIN by the Numbers
38
Active Clinical Trials
1400
Participating Institutions
67
International Sites
21000
Individual Members
Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).
